-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics shareholders approved 750,000-share increase to 2024 equity incentive plan at annual meeting

PUBT·06/16/2026 12:32:13
Listen to the news
Palvella Therapeutics shareholders approved 750,000-share increase to 2024 equity incentive plan at annual meeting
  • Palvella Therapeutics held its annual shareholder meeting on June 10, 2026.
  • Shareholders adopted an amendment to the 2024 Equity Incentive Plan, increasing the share reserve by 750,000 shares; the change took effect immediately.
  • Investors ratified Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.
  • Three directors were selected to serve as Class III directors through the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-074338), on June 16, 2026, and is solely responsible for the information contained therein.